ANIP ANI Pharmaceuticals Inc
$69.62
ANI Pharmaceuticals Inc (ANIP) Earnings News
Earnings press releases, previews and reviews for ANI Pharmaceuticals Inc (ANIP), newest first. Our most recent is review: ANI Pharmaceuticals Beats on Diversified Strength, but a Second Cortrophin Guidance Cut Overshadows the Egetis Deal.
Thursday
November 5, 2026
10:46 AM ET
ANI Pharmaceuticals Beats on Diversified Strength, but a Second Cortrophin Guidance Cut Overshadows the Egetis Deal
Earnings Whispers · Review
Thursday
November 5, 2026
6:51 AM ET
ANI Pharmaceuticals Reports Third Quarter 2026 Financial Results
Wednesday
October 28, 2026
1:05 PM ET
ANI Pharmaceuticals Needs Cortrophin to Hit Its Trimmed Third-Quarter Guide as the Gout Launch Faces Scrutiny
Earnings Whispers · Preview
Friday
October 23, 2026
6:55 AM ET
ANI Pharmaceuticals to Discuss Third Quarter 2026 Financial Results on November 5, 2026 at 8:00 a.m. ET
Friday
August 7, 2026
6:50 AM ET
ANI Pharmaceuticals Reports Record Second Quarter 2026 Financial Results
Friday
July 24, 2026
6:50 AM ET
ANI Pharmaceuticals to Discuss Second Quarter 2026 Financial Results on August 7, 2026 at 8:00 a.m. ET
Friday
May 8, 2026
6:50 AM ET
ANI Pharmaceuticals Reports First Quarter 2026 Financial Results and Raises 2026 Financial Guidance